ARTICLE | Company News
University of Minnesota, Fate Therapeutics deal
July 20, 2015 7:00 AM UTC
Fate partnered with the university to develop NK cell-based, off-the-shelf immunotherapies for cancer. The deal combines the university’s technology to produce persistent NK cells with Fate’s cell pro...